MedTrace Logo

Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

NCT04578509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5197

Last updated 2026-03-09

No results posted yet for this study

Summary

The investigators hypothesize that detection of SARS-CoV2 on saliva samples will increase the performance of the screening program compared to the reference strategy (RT-PCR on a nasopharyngeal swab).

Conditions

Interventions

DIAGNOSTIC_TEST

Nasopharyngeal swab

Research of SARS-CoV-2 infection in nasopharyngeal swab by RT-PCR and by antigenic test

DIAGNOSTIC_TEST

Saliva sample

Research of SARS-CoV-2 infection in saliva samples by RT-PCR and by new detection approach

DIAGNOSTIC_TEST

axillary sweat sample

Research of volatile olfactory compounds of SARS-CoV-2 infection by canine detection on axillary sweat.

OTHER

Data collection

Demographics, symptoms, medical history, acceptability of specimen, consumption in precedents hours are collected

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Jérôme Le Goff, Professor · Assistance Publique - Hôpitaux de Paris

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-19
Primary Completion
2021-06-09
Completion
2021-06-09

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04578509 on ClinicalTrials.gov